Key Details
Last Dividend
$0.02Annual ROE
-782.60%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Jan 14, 2025Recent annual earnings:
Mar 31, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
Dec 19, 2024Next split:
N/ARecent split:
Feb 10, 2020Analyst ratings
Recent major analysts updates
Jun 6, 23 Laidlaw & Co.
HoldJun 6, 23 HC Wainwright & Co.
BuyMay 9, 23 Laidlaw & Co.
BuyApr 4, 23 HC Wainwright & Co.
BuyNov 25, 20 SunTrust Robinson Humphrey
BuyNov 25, 20 Maxim Group
BuyNov 25, 20 Leerink Swann
OutperformNov 25, 20 Jefferies
BuyNov 25, 20 H.C. Wainwright
BuyNov 25, 20 Cowen & Co.
Screeners with BLPH included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Events
Dividend per share
Dividend yield
Other
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Similar stocks
FAQ
- What is the ticker symbol for Bellerophon Therapeutics?
- Does Bellerophon Therapeutics pay dividends?
- What sector is Bellerophon Therapeutics in?
- What industry is Bellerophon Therapeutics in?
- What country is Bellerophon Therapeutics based in?
- When did Bellerophon Therapeutics go public?
- Is Bellerophon Therapeutics in the S&P 500?
- Is Bellerophon Therapeutics in the NASDAQ 100?
- Is Bellerophon Therapeutics in the Dow Jones?
- When was Bellerophon Therapeutics's last earnings report?
- When does Bellerophon Therapeutics report earnings?
- Should I buy Bellerophon Therapeutics stock now?
What is the ticker symbol for Bellerophon Therapeutics?
The ticker symbol for Bellerophon Therapeutics is NASDAQ:BLPH
Does Bellerophon Therapeutics pay dividends?
No, Bellerophon Therapeutics does not pay dividends
What sector is Bellerophon Therapeutics in?
Bellerophon Therapeutics is in the Healthcare sector
What industry is Bellerophon Therapeutics in?
Bellerophon Therapeutics is in the Biotechnology industry
What country is Bellerophon Therapeutics based in?
Bellerophon Therapeutics is headquartered in United States
When did Bellerophon Therapeutics go public?
Bellerophon Therapeutics's initial public offering (IPO) was on February 13, 2015
Is Bellerophon Therapeutics in the S&P 500?
No, Bellerophon Therapeutics is not included in the S&P 500 index
Is Bellerophon Therapeutics in the NASDAQ 100?
No, Bellerophon Therapeutics is not included in the NASDAQ 100 index
Is Bellerophon Therapeutics in the Dow Jones?
No, Bellerophon Therapeutics is not included in the Dow Jones index
When was Bellerophon Therapeutics's last earnings report?
Bellerophon Therapeutics's most recent earnings report was on Jan 14, 2025
When does Bellerophon Therapeutics report earnings?
The date for Bellerophon Therapeutics's next earnings report has not been announced yet
Should I buy Bellerophon Therapeutics stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions